Regulation of the myelin gene periaxin provides evidence for Krox-20-independent myelin-related signalling in Schwann cells

Molecular and Cellular Neuroscience

Volumn 23, Issue 1, 2003, Pages 13-27

  Parkinson, David B ^a   Dickinson, Sarah ^a   Bhaskaran, Ambily ^a   Kinsella, Matthew T ^a   Brophy, Peter J ^b   Sherman, Diane L ^b   Sharghi Namini, Soheila ^a   Duran Alonso, Maria B ^a   Mirsky, Rhona ^a   Jessen, Kristjan R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; MESSENGER RNA; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; PERIAXIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EGR 2; TRANSCRIPTION FACTOR NAB2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EMBRYO; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; IMMUNOREACTIVITY; MYELINATION; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCHWANN CELL; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 0038512226     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00024-1     Document Type: Article

References (45)

1. Archelos J.J., Roggenbuck K., Schneider-Schaulics J., Linington C., Toyka K.V., Hartung H.P. Production and characterisation of monoclonal antibodies to the extracellular domain of P0. J. Neurosci. Res. 35:1993;46-53.
2. Blanchard A.D., Sinanan A., Parmantier E., Zwart R., Broos L., Meijer D., Jessen K.R., Mirsky R. Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells comparison with Oct-1, Krox-20 and Pax-3 . J. Neurosci. Res. 46:1996;630-640.
3. Boerkoel C.F., Takashima H., Bacino C.A., Daentl D., Lupski J.R. EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy. Neurogenetics. 3:2001;153-157.
4. Brockes J.P., Fields K.L., Raff M.C. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res. 165:1979;105-118.
5. Dong Z., Sinanan A., Parkinson D., Parmantier E., Mirsky R., Jessen K.R. Schwann cell development in embryonic mouse nerves. J. Neurosci. Res. 56:1999;334-348.
6. Dytrych L., Sherman D.L., Gillespie C.S., Brophy P.J. Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells. J. Biol. Chem. 273:1998;5794-5800.
7. Evan G.I., Lewis G.K., Ramsay G., Bishop J.M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:1985;3610-3616.
8. Fanning A.S., Anderson J.M. PDZ domains fundamental building blocks in the organization of protein complexes at the plasma membrane . J. Clin. Invest. 103:1999;767-772.
9. Ghislain J., Desmarquet-Trin-Dinh C., Jaegle M., Meijer D., Charnay P., Frain M. Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development. Development. 129:2002;155-166.
10. Gillespie C.S., Sherman D.L., Blair G.E., Brophy P.J. Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron. 12:1994;497-508.
11. Gillespie C.S., Sherman D.L., Fleetwood-Walker S.M., Cottrell D.F., Tait S., Garry E.M., Wallace V.C., Ure J., Griffiths I.R., Smith A., Brophy P.J. Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron. 26:2000;523-531.
12. Guilbot A., Williams A., Ravise N., Verny C., Brice A., Sherman D.L., Brophy P.J., LeGuern E., Delague V., Bareil C., Megarbane A., Claustres M. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum. Mol. Genet. 10:2001;415-421.
13. Jessen K.R., Morgan L., Stewart H.J., Mirsky R. Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP development and regulation by neuron-Schwann cell interactions . Development. 109:1990;91-103.
14. Jessen K.R., Mirsky R. Schwann cells early lineage, regulation of proliferation and control of myelin formation . Curr. Opin. Neurobiol. 2:1992;575-581.
15. Jessen K.R., Brennan A., Morgan L., Mirsky R., Kent A., Hashimoto Y., Gavrilovic J. The Schwann cell precursor and its fate a study of cell death and differentiation during gliogenesis in rat embryonic nerves . Neuron. 12:1994;509-527.
16. Kondo T., Raff M. The Id4 HLH protein and the timing of oligodendrocyte differentiation. EMBO J. 19:2000;1998-2007.
17. 0 is constitutively expressed in the rat neural crest and embryonic nerves and is negatively and positively regulated by axons to generate non-myelin-forming and myelin-forming Schwann cells, respectively. Mol. Cell. Neurosci. 8:1997;336-350.
18. Lemke G., Axel R. Protein isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell. 40:1985;501-508.
19. Lemke G., Chao M. Axons regulate Schwann cell expression of the major myelin and NGF receptor genes. Development. 102:1988;499-504.
20. Martini R., Schachner M. Immunoelectron microscopic localization of neural cell adhesion molecules (L1, N-CAM, and MAG) and their shared carbohydrate epitope and myelin basic protein in developing sciatic nerve. J. Cell Biol. 103:1986;2439-2448.
21. Martini R., Xin Y., Schachner M. Restricted localisation of L1 and NCAM at sites of contact between Schwann cells and neurites in culture. Glia. 10:1994;70-74.
22. Mechta-Grigoriou F., Garel S., Charnay P. Nab proteins mediate a negative feedback loop controlling Krox-20 activity in the developing hindbrain. Development. 127:2000;119-128.
23. Mirsky R., Jessen K.R. The neurobiology of Schwann cells. Brain Pathol. 9:1999;293-311.
24. Mirsky, R., Jessen, K.R., 2001. Embryonic and early postnatal development of Schwann cells, in: Jessen, K.R., Richardson, W.D. (Eds.), Glial Cell Development: Basic Principles and Clinical Relevance, 2nd ed., Oxford University Press, pp. 1-20.
25. -) depends on growth inhibition . J. Cell Biol. 112:1991;457-467.
26. 0 mRNA and protein induction in cultured Schwann cells by FGF2 and TGFβ1, TGFβ2 and TGFβ3 . Development. 120:1994;1399-1409.
27. Morgenstern J.P., Land H. A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res. 18:1990;1068.
28. Nagarajan R., Svaren J., Le N., Araki T., Watson M., Milbrandt J. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron. 30:2001;355-368.
29. Owens G.C., Boyd C.J. Expressing antisense P0 RNA in Schwann cells perturbs myelination. Development. 112:1991;639-649.
30. Parkinson D., Dong Z., Bunting H., Whitfield J., Meier C., Marie H., Mirsky R., Jessen K.R. TGFβ mediates Schwann cell death in vitro and in vivo examination of c-Jun activation, interactions with survival signals, and the relationship of TGFβ mediated death to Schwann cell differentiation . J. Neurosci. 21:2001;8572-8585.
31. Quarles R.H. Glycoproteins of myelin sheaths. J. Mol. Neurosci. 8:1997;1-12.
32. Scherer S.S., Xu Y.T., Bannerman P.G., Sherman D.L., Brophy P.J. Periaxin expression in myelinating Schwann cells modulation by axon-glial interactions and polarized localization during development . Development. 121:1995;4265-4273.
33. Schneider-Maunoury S., Topilko P., Seitandou T., Levi G., Cohen-Tannoudji M., Pournin S., Babinet C., Charnay P. Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell. 75:1993;1199-1214.
34. Sevetson B., Svaren J., Milbrandt J. A novel activation function for NAB proteins in Egr-dependent transcription of the luteinizing hormone-beta gene. J. Biol. Chem. 275:2000;9749-9757.
35. Sherman D.L., Brophy P.J. A tripartite nuclear localization signal in the PDZ-domain protein L-periaxin. J. Biol. Chem. 275:2000;4537-4540.
36. Sherman D.L., Fabrizi C., Gillespie C.S., Brophy P.J. Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy. Neuron. 30:2001;677-687.
37. Svaren J., Sevetson B.R., Apel E.D., Zimonjic D.B., Popescu N.C., Milbrandt J. NAB2, a corepressor of NGF1-A (Egr-1) and Krox-20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol. 16:1996;3545-3553.
38. Sweadner K.J. Post-translational modification and evoked release of two large surface proteins of sympathetic neurons. J. Neurosci. 3:1983;2504-2517.
39. Swirnoff A.H., Apel A.D., Svaren J., Sevetson B.R., Zimonjic D.B., Popescu N.C., Milbrandt J. NAB1, a co-repressor of NGF1-A (Egr-1), contains an active transcriptional repression domain. Mol. Cell. Biol. 18:1998;512-524.
40. Topilko P., Schneider-Maunoury S., Levi G., Baron-Van Evercooren A., Chennoufi A.B., Seitanidou T., Babinet C., Charnay P. Krox-20 controls myelination in the peripheral nervous system. Nature. 371:1994;796-799.
41. Vesque C., Charnay P. Mapping functional regions of the segment-specific transcription factor Krox-20. Nucleic Acids Res. 20:1992;2485-2492.
42. Warner L.E., Mancias P., Butler I.J., McDonald C.M., Keppen L., Koob K.G., Lupski J.R. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nature Genet. 18:1998;382-384.
43. Warner L.E., Svaren J., Milbrandt J., Lupski J.R. Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum. Mol. Genet. 8:1999;1245-1251.
44. Zorick T.S., Syroid D.E., Arroyo E., Scherer S.S., Lemke G. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol. Cell. Neurosci. 8:1996;129-145.
45. Zorick T.S., Syroid D.E., Brown A., Gridley T., Lemke G. Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells. Development. 126:1999;1397-1406.